Cart
sales@molnova.com
Celosin H
CAS No. 1623405-28-6
Celosin H( —— )
Catalog No. M29432 CAS No. 1623405-28-6
Celosin H is a novel hepatoprotective triterpenoid saponin isolated from the methanol extract of Celosiae Semen.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 228 | In Stock |
|
| 5MG | 70 | In Stock |
|
| 10MG | 104 | In Stock |
|
| 25MG | 170 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCelosin H
-
NoteResearch use only, not for human use.
-
Brief DescriptionCelosin H is a novel hepatoprotective triterpenoid saponin isolated from the methanol extract of Celosiae Semen.
-
DescriptionCelosin H is a novel hepatoprotective triterpenoid saponin isolated from the methanol extract of Celosiae Semen.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1623405-28-6
-
Formula Weight957.073
-
Molecular FormulaC47H72O20
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]12CC(C)(C)CC[C@@]1(CC[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)C[C@@H](O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O)[C@H](O[C@@H]5OC[C@@H](O)[C@H](O)[C@H]5O)[C@H]4O)C(O)=O)[C@](C)(C=O)[C@]3([H])CC[C@@]12C)C(=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Leteprinim
Leteprinim is an hypoxanthine derivative that stimulates in vitro neurite outgrowth and the production of adenosine and neurotrophins from astrocytes.
-
Anticancer agent 46
Anticancer agent 46 is a potent anti-cancer agent, showing anti-proliferative activity in cellular assays, with an IC50 of 0.986 μM against MGC803 cells.
-
VPC-18005
VPC-18005 is a luciferase inhibitor. VPC-18005 inhibits ERG-induced transcription and interacts directly with the ERG-ETS domain thereby disrupting the ERG binding to DNA.
